BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 17991884)

  • 1. Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts.
    Li P; Wang D; Lucas J; Oparil S; Xing D; Cao X; Novak L; Renfrow MB; Chen YF
    Circ Res; 2008 Feb; 102(2):185-92. PubMed ID: 17991884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic GMP/protein kinase G phosphorylation of Smad3 blocks transforming growth factor-beta-induced nuclear Smad translocation: a key antifibrogenic mechanism of atrial natriuretic peptide.
    Buxton IL; Duan D
    Circ Res; 2008 Feb; 102(2):151-3. PubMed ID: 18239144
    [No Abstract]   [Full Text] [Related]  

  • 3. ANP signaling inhibits TGF-beta-induced Smad2 and Smad3 nuclear translocation and extracellular matrix expression in rat pulmonary arterial smooth muscle cells.
    Li P; Oparil S; Novak L; Cao X; Shi W; Lucas J; Chen YF
    J Appl Physiol (1985); 2007 Jan; 102(1):390-8. PubMed ID: 17038494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts.
    Liu X; Sun SQ; Hassid A; Ostrom RS
    Mol Pharmacol; 2006 Dec; 70(6):1992-2003. PubMed ID: 16959941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The mechanism of transforming growth factor beta1 in myofibroblast differentiation].
    Liu HX; Wang SW; Zhao CH; Liu Y; Li Y; Zhang QG; Cong W; Lan XG; Xu S; Han LB; Zhang L
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):986-9. PubMed ID: 17961388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide regulates transforming growth factor-beta signaling in endothelial cells.
    Saura M; Zaragoza C; Herranz B; Griera M; Diez-Marqués L; Rodriguez-Puyol D; Rodriguez-Puyol M
    Circ Res; 2005 Nov; 97(11):1115-23. PubMed ID: 16239590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of transforming growth factor-beta1/Smad3 signaling in bronchiolitis obliterans following lung transplantation].
    Liu HX; Li Y; Zhao CH; Liu Y; Zhang QG; Cong W; Lan XG; Xu S; Han LB; Zhang L
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(29):2069-73. PubMed ID: 17925182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
    Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
    Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
    Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
    Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
    Gu L; Zhu YJ; Yang X; Guo ZJ; Xu WB; Tian XL
    Acta Pharmacol Sin; 2007 Mar; 28(3):382-91. PubMed ID: 17303001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
    Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
    Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway.
    Xiao H; Ma X; Feng W; Fu Y; Lu Z; Xu M; Shen Q; Zhu Y; Zhang Y
    Cardiovasc Res; 2010 Aug; 87(3):504-13. PubMed ID: 20200042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin-1 increases basal and TGF-beta1-induced expression of type I procollagen through PI-3 kinase/Akt/mTOR pathway in human dermal fibroblasts.
    Kim S; Lee Y; Seo JE; Cho KH; Chung JH
    Cell Signal; 2008 Jul; 20(7):1313-9. PubMed ID: 18434090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
    Yoo YA; Kang MH; Kim JS; Oh SC
    Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL18-stimulated upregulation of collagen production in lung fibroblasts requires Sp1 signaling and basal Smad3 activity.
    Luzina IG; Tsymbalyuk N; Choi J; Hasday JD; Atamas SP
    J Cell Physiol; 2006 Jan; 206(1):221-8. PubMed ID: 16021625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
    Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta regulates differentially the proliferation of fetal and adult human skin fibroblasts via the activation of PKA and the autocrine action of FGF-2.
    Giannouli CC; Kletsas D
    Cell Signal; 2006 Sep; 18(9):1417-29. PubMed ID: 16361081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression.
    Jinnin M; Ihn H; Tamaki K
    Mol Pharmacol; 2006 Feb; 69(2):597-607. PubMed ID: 16288083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury.
    Kobayashi K; Yokote K; Fujimoto M; Yamashita K; Sakamoto A; Kitahara M; Kawamura H; Maezawa Y; Asaumi S; Tokuhisa T; Mori S; Saito Y
    Circ Res; 2005 Apr; 96(8):904-12. PubMed ID: 15790953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition.
    Peng SB; Yan L; Xia X; Watkins SA; Brooks HB; Beight D; Herron DK; Jones ML; Lampe JW; McMillen WT; Mort N; Sawyer JS; Yingling JM
    Biochemistry; 2005 Feb; 44(7):2293-304. PubMed ID: 15709742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.